EP3013366
COMBINATION THERAPY USING A FACTOR XII INHIBITOR AND A C1-INHIBITOR
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
27.6.2014EP published:
25.8.2021EP application number:
14739078.5
EPO information:
European Patent Register
Max expiry date:
26.6.2034
Title:
COMBINATION THERAPY USING A FACTOR XII INHIBITOR AND A C1-INHIBITOR
Timeline
Today
27.6.2014EP application
25.8.2021EP Publication
Owner
Name:
CSL Behring GmbHAddress:
Emil-von-Behring-Strasse 76, 35041 Marburg, DE
Inventor
Name:
NOLTE, MarcAddress:
35041 Marburg, DE
Name:
PRAGST, IngoAddress:
34549 Edertal, DE
Priority
Number:
201361840662 PDate:
28.6.2013Country:
US
Number:
13176605Date:
16.7.2013Country:
EP
Classification
Categories:
A61K 38/57, A61K 39/395, A61K 31/4365, A61K 31/519, A61K 31/60, A61K 31/616, A61K 31/727, A61K 45/06, C07K 16/36, A61P 3/00, A61P 7/02, A61P 7/10, A61P 9/00, A61P 9/10, A61P 11/00, A61P 21/00, A61P 25/00, A61P 29/00, A61P 43/00